95 related articles for article (PubMed ID: 29766361)
1. Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants.
Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Infante M; Durán M; Marcos G; Lastra E; Gómez-Barrero S; Velasco EA
Breast Cancer Res Treat; 2018 Aug; 171(1):53-63. PubMed ID: 29766361
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
Dos Santos ES; Caputo SM; Castera L; Gendrot M; Briaux A; Breault M; Krieger S; Rogan PK; Mucaki EJ; Burke LJ; ; Bièche I; Houdayer C; Vaur D; Stoppa-Lyonnet D; Brown MA; Lallemand F; Rouleau E
Breast Cancer Res Treat; 2018 Apr; 168(2):311-325. PubMed ID: 29236234
[TBL] [Abstract][Full Text] [Related]
3. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
[TBL] [Abstract][Full Text] [Related]
4. Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.
Maia AT; Antoniou AC; O'Reilly M; Samarajiwa S; Dunning M; Kartsonaki C; Chin SF; Curtis CN; McGuffog L; Domchek SM; ; Easton DF; Peock S; Frost D; Evans DG; Eeles R; Izatt L; Adlard J; Eccles D; ; Sinilnikova OM; Mazoyer S; Stoppa-Lyonnet D; Gauthier-Villars M; Faivre L; Venat-Bouvet L; Delnatte C; Nevanlinna H; Couch FJ; Godwin AK; Caligo MA; ; Barkardottir RB; ; Chen X; Beesley J; Healey S; Caldas C; Chenevix-Trench G; Ponder BA
Breast Cancer Res; 2012 Apr; 14(2):R63. PubMed ID: 22513257
[TBL] [Abstract][Full Text] [Related]
5. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
6. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.
Sanz DJ; Acedo A; Infante M; Durán M; Pérez-Cabornero L; Esteban-Cardeñosa E; Lastra E; Pagani F; Miner C; Velasco EA
Clin Cancer Res; 2010 Mar; 16(6):1957-67. PubMed ID: 20215541
[TBL] [Abstract][Full Text] [Related]
7. rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.
Cao J; Luo C; Yan R; Peng R; Wang K; Wang P; Ye H; Song C
Med Oncol; 2016 Dec; 33(12):135. PubMed ID: 27807724
[TBL] [Abstract][Full Text] [Related]
8. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene.
Bayerer B; Stamer U; Hoeft A; Stüber F
Eur J Pain; 2007 May; 11(4):421-7. PubMed ID: 16843022
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.
Misra S; Sharma S; Agarwal A; Khedkar SV; Tripathi MK; Mittal MK; Chaudhuri G
Mol Cancer; 2010 Mar; 9():50. PubMed ID: 20202217
[TBL] [Abstract][Full Text] [Related]
11. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR
J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278
[TBL] [Abstract][Full Text] [Related]
12. Regulatory single nucleotide polymorphisms (rSNPs) at the promoters 1A and 1B of the human APC gene.
Matveeva MY; Kashina EV; Reshetnikov VV; Bryzgalov LO; Antontseva EV; Bondar NP; Merkulova TI
BMC Genet; 2016 Dec; 17(Suppl 3):154. PubMed ID: 28105931
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional analyses of polymorphism haplotypes of protein phosphatase 2A-Aα gene promoter.
Lin YC; Chen HF; Lin LN; Luo J; Li W; Zhang SJ; Li XJ; Hu YM; Chen YX; Chen W; Lin ZN
Mutat Res; 2011 Nov; 716(1-2):66-75. PubMed ID: 21889517
[TBL] [Abstract][Full Text] [Related]
14. Effect of the expression of BRCA2 on spontaneous homologous recombination and DNA damage-induced nuclear foci in Saccharomyces cerevisiae.
Spugnesi L; Balia C; Collavoli A; Falaschi E; Quercioli V; Caligo MA; Galli A
Mutagenesis; 2013 Mar; 28(2):187-95. PubMed ID: 23328489
[TBL] [Abstract][Full Text] [Related]
15. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
16. Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.
Elimam AA; Aabdein MEMM; Eldeen MEM; Altayb HN; Taha MA; Nimir MN; Dafaalla MD; Alfaki MM; Abdelrahim MA; Abdalla AA; Mohammed MI; Ellaithi M; Hamid MMA; Hassan MAS
BMC Med Genet; 2017 Aug; 18(1):85. PubMed ID: 28814288
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.
Gabaldó Barrios X; Sarabia Meseguer MD; Marín Vera M; Sánchez Bermúdez AI; Macías Cerrolaza JA; Sánchez Henarejos P; Zafra Poves M; García Hernández MR; Cuevas Tortosa E; Aliaga Baño Á; Castillo Guardiola V; Martínez Hernández P; Tovar Zapata I; Martínez Barba E; Ayala de la Peña F; Alonso Romero JL; Noguera Velasco JA; Ruiz Espejo F
Fam Cancer; 2017 Oct; 16(4):477-489. PubMed ID: 28477318
[TBL] [Abstract][Full Text] [Related]
18. TSS seq based core promoter architecture in blood feeding Tsetse fly (Glossina morsitans morsitans) vector of Trypanosomiasis.
Mwangi S; Attardo G; Suzuki Y; Aksoy S; Christoffels A
BMC Genomics; 2015 Sep; 16(1):722. PubMed ID: 26394619
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia.
Jakimovska M; Maleva Kostovska I; Popovska-Jankovic K; Kubelka-Sabit K; Karadjozov M; Stojanovska L; Arsovski A; Smichkoska S; Lazarova E; Jakimovska Dimitrovska M; Plaseska-Karanfilska D
Breast Cancer Res Treat; 2018 Apr; 168(3):745-753. PubMed ID: 29335924
[TBL] [Abstract][Full Text] [Related]
20. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
Thomassen M; Blanco A; Montagna M; Hansen TV; Pedersen IS; Gutiérrez-Enríquez S; Menéndez M; Fachal L; Santamariña M; Steffensen AY; Jønson L; Agata S; Whiley P; Tognazzo S; Tornero E; Jensen UB; Balmaña J; Kruse TA; Goldgar DE; Lázaro C; Diez O; Spurdle AB; Vega A
Breast Cancer Res Treat; 2012 Apr; 132(3):1009-23. PubMed ID: 21769658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
